• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞-淋巴细胞比值与股浅动脉支架内再狭窄的关系。

The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.

机构信息

Department of Intervention,The fourth affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

出版信息

Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193448.

DOI:10.1042/BSR20193448
PMID:32583853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7332680/
Abstract

The present study aimed to investigate the relationship between an increase in the pre- and post-operative neutrophil-lymphocyte ratio (NLR) and superficial femoral artery in-stent restenosis (ISR) rate. We recruited 199 patients that underwent superficial femoral artery stenting for lower extremity arteriosclerosis obliterans at our hospital from March 2015 to July 2018. Patients were divided into two groups according to the occurrence of ISR within 1 year (group 1, ISR and group 2, Non-ISR). The after NLR (NLRafter) and NLR change ratio (NLRratio) (P<0.001) were significantly higher in group 1. A NLRafter > 4.3 was associated with an odds ratio of 1.946 (95% CI [1.51-2.50]; P<0.001) for the presence of ISR. A NLRratio > 37.5% was associated with an odds ratio of 3.6 (95% CI [2.03-6.36]; P<0.001) for occurrence of ISR. A NLRafter level > 4.3 had 75% sensitivity and 76% specificity for the prediction of ISR, as identified by the ROC curve. A NLRratio level > 37.5% predicted ISR with 77% sensitivity and 60% specificity. Multivariate logistic regression analysis demonstrated that NLRratio was the strongest independent predictor of ISR (P<0.001). In conclusions, NLRratio could be used as a prognostic marker in superficial femoral artery stents.

摘要

本研究旨在探讨术前和术后中性粒细胞/淋巴细胞比值(NLR)与股浅动脉支架内再狭窄(ISR)发生率之间的关系。我们招募了 199 名 2015 年 3 月至 2018 年 7 月在我院因下肢动脉硬化闭塞症接受股浅动脉支架置入术的患者。根据术后 1 年内是否发生 ISR 将患者分为两组(组 1:ISR;组 2:非 ISR)。组 1 的 NLR 术后值(NLRafter)和 NLR 变化率(NLRratio)显著升高(P<0.001)。NLRafter>4.3 与 ISR 发生的比值比(OR)为 1.946(95%CI [1.51-2.50];P<0.001)。NLRratio>37.5%与 ISR 发生的 OR 为 3.6(95%CI [2.03-6.36];P<0.001)。NLRafter 水平>4.3 预测 ISR 的敏感性为 75%,特异性为 76%,ROC 曲线分析结果表明。NLRratio 水平>37.5%预测 ISR 的敏感性为 77%,特异性为 60%。多变量 logistic 回归分析表明,NLRratio 是 ISR 的最强独立预测因子(P<0.001)。总之,NLRratio 可作为股浅动脉支架的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d4b/7332680/d51488d99187/bsr-40-bsr20193448-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d4b/7332680/d51488d99187/bsr-40-bsr20193448-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d4b/7332680/d51488d99187/bsr-40-bsr20193448-g1.jpg

相似文献

1
The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.中性粒细胞-淋巴细胞比值与股浅动脉支架内再狭窄的关系。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193448.
2
A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume.股浅动脉支架植入术后再狭窄的风险预测指标:血小板平均体积的相关性。
BMC Cardiovasc Disord. 2020 Aug 8;20(1):361. doi: 10.1186/s12872-020-01633-8.
3
Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.血管内超声衍生的支架尺寸作为股浅动脉镍钛诺支架植入术后血管造影再狭窄的预测指标
J Endovasc Ther. 2016 Jun;23(3):424-32. doi: 10.1177/1526602816641669. Epub 2016 Apr 4.
4
Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation.术前炎症状态作为股腘动脉支架植入术后原发性通畅的预测指标。
J Vasc Surg. 2017 Jul;66(1):151-159. doi: 10.1016/j.jvs.2017.01.031. Epub 2017 Mar 1.
5
Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.紫杉醇洗脱球囊与标准血管成形术治疗股浅动脉和腘动脉近端支架内再狭窄糖尿病患者以降低再狭窄:DEBATE-ISR研究的三年结果
J Endovasc Ther. 2016 Feb;23(1):52-7. doi: 10.1177/1526602815614555. Epub 2015 Oct 28.
6
Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.中性粒细胞与淋巴细胞比值用于预测分叉病变支架内再狭窄
Eur Rev Med Pharmacol Sci. 2015 May;19(10):1866-73.
7
Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.准分子激光血管成形术治疗股腘动脉支架内再狭窄
J Endovasc Ther. 2015 Aug;22(4):506-13. doi: 10.1177/1526602815592133. Epub 2015 Jun 30.
8
High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.高剂量率近距离放射疗法治疗下肢支架内再狭窄
J Vasc Surg. 2017 Mar;65(3):734-743. doi: 10.1016/j.jvs.2016.10.002. Epub 2016 Dec 13.
9
Stent implantation in the superficial femoral artery: short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis.股浅动脉支架植入术:短血栓弹力描记术衍生的凝血时间可识别支架内再狭窄的迟发患者。
Thromb Res. 2012 Sep;130(3):485-90. doi: 10.1016/j.thromres.2012.04.007. Epub 2012 Apr 29.
10
Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测下肢动脉硬化闭塞症的严重程度和预后。
Ann Vasc Surg. 2020 Apr;64:221-227. doi: 10.1016/j.avsg.2019.09.005. Epub 2019 Oct 23.

引用本文的文献

1
Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting in-stent restenosis: A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值作为预测支架内再狭窄的潜在生物标志物:一项系统评价和荟萃分析。
PLoS One. 2025 May 16;20(5):e0322461. doi: 10.1371/journal.pone.0322461. eCollection 2025.
2
Inflammatory-Related Biomarkers in Patients Undergoing Percutaneous Transluminal Angioplasty for Femoropopliteal Artery Lesions.接受股腘动脉病变经皮腔内血管成形术患者的炎症相关生物标志物
Acta Cardiol Sin. 2025 Jan;41(1):138-147. doi: 10.6515/ACS.202501_41(1).20241024A.
3
A systematic review of clinical and biomechanical engineering perspectives on the prediction of restenosis in coronary and peripheral arteries.

本文引用的文献

1
The Relationship Between the Neutrophil-Lymphocyte Ratio and In-Stent Restenosis in Patients With Femoropopliteal Chronic Total Occlusions.股腘动脉慢性完全闭塞患者中性粒细胞与淋巴细胞比值与支架内再狭窄的关系
Angiology. 2018 Feb;69(2):177-182. doi: 10.1177/0003319717714918. Epub 2017 Jun 21.
2
Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.中性粒细胞与淋巴细胞比值用于预测分叉病变支架内再狭窄
Eur Rev Med Pharmacol Sci. 2015 May;19(10):1866-73.
3
Neutrophil to lymphocyte ratio is associated with more extensive, severe and complex coronary artery disease and impaired myocardial perfusion.
冠状动脉和外周动脉再狭窄预测的临床与生物力学工程视角的系统综述。
JVS Vasc Sci. 2023 Sep 15;4:100128. doi: 10.1016/j.jvssci.2023.100128. eCollection 2023.
4
Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia.经皮腔内血管成形术治疗严重肢体缺血患者再狭窄的标志物。
Int J Mol Sci. 2023 May 22;24(10):9096. doi: 10.3390/ijms24109096.
5
A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis.预测经皮冠状动脉介入治疗患者支架内再狭窄风险的列线图:基于人群的分析
Int J Gen Med. 2022 Mar 3;15:2451-2461. doi: 10.2147/IJGM.S357250. eCollection 2022.
6
Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.糖尿病患者支架内再狭窄的发病机制及临床意义。
Int J Environ Res Public Health. 2021 Nov 15;18(22):11970. doi: 10.3390/ijerph182211970.
中性粒细胞与淋巴细胞比值与更广泛、严重和复杂的冠状动脉疾病以及心肌灌注受损有关。
Turk Kardiyol Dern Ars. 2014 Mar;42(2):125-30. doi: 10.5543/tkda.2014.18949.
4
In-stent restenosis in the superficial femoral artery.股浅动脉支架内再狭窄
Ann Vasc Surg. 2013 May;27(4):510-24. doi: 10.1016/j.avsg.2012.09.005. Epub 2013 Mar 25.
5
Mechanisms of post-intervention arterial remodelling.介入治疗后动脉重塑的机制。
Cardiovasc Res. 2012 Dec 1;96(3):363-71. doi: 10.1093/cvr/cvs276. Epub 2012 Aug 22.
6
Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.中性粒细胞与淋巴细胞比值预测金属裸支架再狭窄的价值。
Am J Cardiol. 2012 Nov 15;110(10):1405-10. doi: 10.1016/j.amjcard.2012.07.003. Epub 2012 Aug 2.
7
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.血管炎症与修复:对再内皮化、再狭窄和支架内血栓形成的影响。
JACC Cardiovasc Interv. 2011 Oct;4(10):1057-66. doi: 10.1016/j.jcin.2011.05.025.
8
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
9
The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI.血清尿酸水平与 STEMI 患者行直接经皮冠状动脉介入治疗后冠状动脉血流的关系。
Atherosclerosis. 2011 Nov;219(1):334-41. doi: 10.1016/j.atherosclerosis.2011.07.021. Epub 2011 Jul 22.
10
Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts.外周血管腔内支架置入术的炎症标志物与再狭窄:当前概念
Ann Vasc Surg. 2011 Aug;25(6):846-55. doi: 10.1016/j.avsg.2011.02.026. Epub 2011 May 28.